ARTG Entry

TZIELD

ARTG entry for TZIELD (teplizumab), ARTG 476208 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Sanofi-Aventis
• Active ingredient: teplizumab
• Therapeutic area: Endocrinology

TGA Public Summary — ARTG 476208